Forte Biosciences (NASDAQ: FBRX) and D-Wave Quantum (NASDAQ: QBTS) stocks have risen more than 20% in Monday’s trading session, entering the list of the day’s top-performing assets. These two assets enabled day traders to earn stellar gains that would take other investors a year to realize. The development highlights that the US stock market has several gems that need to be recognized and followed to earn profits.

While Forte Biosciences stock rose nearly 40% in the day’s trade, D-Wave Quantum stock spiked 20%. They remained at the top of the charts the entire day, with no dip in the entire trading session. Both equities could enter traders’ must-watch list as the upside potential is immense. Investors could begin taking entry positions, hoping that it would replicate its success in the near term.

Also Read: How Does Micron Stock Keep Going Up? Here’s What Could Stop the Rally

Why Did Forte Biosciences and D-Wave Quantum Stocks Surge?

Forte Biosciences stock surged on Monday after the Dutch immunology giant, Argenx, announced it would acquire the company for $2.2 billion. The agreement will be an all-cash transaction and could be closed by the third quarter of 2026. The acquisition will allow Argenx to purchase the company for $77 per share. Argenx has agreed to pay a premium primarily to secure Forte Biosciences’s lead asset, FB102, which is an anti-CD122 monoclonal antibody that selectively targets pathogenic T-cell and NK-cell activity.

On the other hand, D-Wave Quantum stock spiked 20% after the company announced expanding its use of quantum computing technology. It broadened its partnership with AT&T to optimize its network processing time from one hour to roughly 15 seconds. This encouraged the telecom giant to sign an agreement with the quantum computing company. The development will help AT&T solve its outage detection, network planning, and traffic management issues. “The speed we’re seeing with D-Wave challenges what’s currently possible,” AT&T executive Lucus Haugen said.